These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

94 related items for PubMed ID: 1733755

  • 21. Hepatotoxic reactions associated with carbamazepine therapy.
    Horowitz S, Patwardhan R, Marcus E.
    Epilepsia; 1988; 29(2):149-54. PubMed ID: 3280305
    [Abstract] [Full Text] [Related]

  • 22. Lateral gaze nystagmus in carbamazepine-treated epileptic patients: correlation with total and free plasma concentrations of parent drug and its 10,11-epoxide metabolite.
    Riva R, Contin M, Albani F, Perucca E, Ambrosetto G, Procaccianti G, Santucci M, Baruzzi A.
    Ther Drug Monit; 1985; 7(3):277-82. PubMed ID: 4049464
    [Abstract] [Full Text] [Related]

  • 23. Carbamazepine therapy and long-term prognosis in epilepsy of childhood.
    Okuno T, Ito M, Nakano S, Hattori H, Fujii T, Go T, Mikawa H.
    Epilepsia; 1989; 30(1):57-61. PubMed ID: 2912717
    [Abstract] [Full Text] [Related]

  • 24. Hyponatremia associated with carbamazepine and oxcarbazepine therapy: a review.
    Van Amelsvoort T, Bakshi R, Devaux CB, Schwabe S.
    Epilepsia; 1994; 35(1):181-8. PubMed ID: 8112243
    [Abstract] [Full Text] [Related]

  • 25. Carbamazepine, phenytoin, sex hormones, and sexual function in men with epilepsy.
    Isojärvi JI, Repo M, Pakarinen AJ, Lukkarinen O, Myllylä VV.
    Epilepsia; 1995 Apr; 36(4):366-70. PubMed ID: 7607115
    [Abstract] [Full Text] [Related]

  • 26.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 27. Improved CNS tolerability following conversion from immediate- to extended-release carbamazepine.
    Miller AD, Krauss GL, Hamzeh FM.
    Acta Neurol Scand; 2004 Jun; 109(6):374-7. PubMed ID: 15147458
    [Abstract] [Full Text] [Related]

  • 28.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 29. Laser evoked potentials and carbamazepine in epileptic patients.
    Galeotti F, Truini A, Iannetti GD, Romaniello A, Biasiotta A, Mascia A, Virtuoso M, Cruccu G.
    Neurophysiol Clin; 2005 Jul; 35(2-3):93-6. PubMed ID: 16087072
    [Abstract] [Full Text] [Related]

  • 30.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 31. Carbamazepine intoxication due to triacetyloleandomycin administration in epileptic patients.
    Mesdjian E, Dravet C, Cenraud B, Roger J.
    Epilepsia; 1980 Oct; 21(5):489-96. PubMed ID: 6968264
    [Abstract] [Full Text] [Related]

  • 32.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 33.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 34. Vitamin D levels and bone turnover in epilepsy patients taking carbamazepine or oxcarbazepine.
    Mintzer S, Boppana P, Toguri J, DeSantis A.
    Epilepsia; 2006 Mar; 47(3):510-5. PubMed ID: 16529614
    [Abstract] [Full Text] [Related]

  • 35.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 36.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 37.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 38. [Carbamazepine-induced diarrhea and eosinophilic inflammation of the colon].
    Anttila VJ, Valtonen M.
    Duodecim; 1990 Mar; 106(4):372-4. PubMed ID: 1670102
    [No Abstract] [Full Text] [Related]

  • 39. Association between carbamazepine-induced cutaneous adverse drug reactions and the HLA-B*1502 allele among patients in central China.
    Wu XT, Hu FY, An DM, Yan B, Jiang X, Kwan P, Stefan H, Zhou D.
    Epilepsy Behav; 2010 Nov; 19(3):405-8. PubMed ID: 20833111
    [Abstract] [Full Text] [Related]

  • 40. Carbamazepine-valnoctamide interaction in epileptic patients: in vitro/in vivo correlation.
    Pisani F, Haj-Yehia A, Fazio A, Artesi C, Oteri G, Perucca E, Kroetz DL, Levy RH, Bialer M.
    Epilepsia; 1993 Nov; 34(5):954-9. PubMed ID: 8104783
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 5.